High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 10, 2011, Pages 776-782

  Molino Lova, R ^a   Macchi, C ^a,b   Gori, A M ^a,b   Marcucci, R ^b   Polcaro, P ^a   Cecchi, F ^a   Lauretani, F ^c   Bandinelli, S ^d   Abbate, R ^b   Beghi, E ^e   Guralnik, J M ^f   Ferrucci, L ^f  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Tuscany Regional Health Agency   (Italy)

^d ASF   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Atherosclerosis; C reactive protein; Carotid arteries; Older persons; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; COHORT ANALYSIS; FEMALE; GENETICS; HUMAN; MALE; PATHOLOGY; PROSPECTIVE STUDY; RISK; SEX DIFFERENCE; SMOKING;

AGE FACTORS; AGED; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID STENOSIS; COHORT STUDIES; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK; SEX FACTORS; SMOKING;

EID: 80053052232     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.02.003     Document Type: Article

References (39)

1. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007, 49:2129-2138.
2. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297:611-619.
3. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008, 118:2243-2251. 4 pp.
4. Ridker P.M. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin Chem 2008, 54:234-237.
5. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Giotto A.M., Kastelein J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
6. Hashimoto H., Kitagawa K., Hougaku H., Shimizu Y., Sakaguchi M., Nagai Y., et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001, 104:63-67.
7. Van der Meer I., De Maat M.P., Hak A.E., Kiliaan A.J., Del Sol A.I., Van der Kuip D.A., et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke 2002, 33:2750-2755.
8. Hashimoto H., Kitagawa K., Hougaku H., Etani H., Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004, 35:1625-1630.
9. Schillinger M., Exner M., Mlekusch W., Sabeti S., Amighi J., Nikowitsch R., et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 2005, 111:2203-2209.
10. Hashimoto H., Kitagawa K., Hougaku H., Etani H., Hori M. C-reactive protein predicts carotid atherosclerosis progression in mild to moderate risk and middle-aged patients. Clin Invest Med 2006, 29:77-82.
11. Elias-Smale S.E., Kardys I., Oudkerk M., Hofman A., Witteman J.C. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007, 195:e195-e202.
12. Arthurs Z.M., Andersen C., Starnes B.W., Sohn V.Y., Mullenix P.S., Perry J. A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis. J Vasc Surg 2008, 47:744-750.
13. Chapman C.M., Beilby J.P., McQuillan B.M., Thompson P.L., Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004, 35:1619-1624.
14. Hee C.S., Chang K.H., Woo A.C., Soo C.B., Chung Y.S., Woo L.K., et al. Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?. Eur J Cardiovasc Prev Rehabil 2005, 12:548-554.
15. Makita S., Nakamura M., Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005, 36:2138-2142.
16. Sander D., Schulze-Horn C., Bickel H., Gnahn H., Bartels E., Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 2006, 37:351-357.
17. Lorenz M.W., Karbstein P., Markus H.S., Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007, 38:1774-1779.
18. Heiss G., Sharrett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134:250-256.
19. Salonen R., Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991, 229:225-231.
20. Mackinnon A.D., Jerrard-Dunne P., Sitzer M., Buehler A., von Kegler S., Markus H.S. Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke 2004, 35:2150-2154.
21. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
22. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109:II2-10.
23. Libby P., Ridker P. Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006, 48:A33-A46.
24. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
25. Lucas A.R., Korol R., Pepine C.J. Inflammation in atherosclerosis: some thoughts about acute coronary syndromes. Circulation 2006, 113:e728-e732.
26. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000, 48:1618-1625.
27. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96:1432-1437.
28. Van Damme H., Vivario M. Pathologic aspects of carotid plaques: surgical and clinical significance. Int Angiol 1993, 12:299-311.
29. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
30. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:S498-S504.
31. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
32. Johnsen S.H., Fosse E., Joakimsen O., Mathiesen E.B., Stensland-Bugge E., Njolstad I., et al. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromso Study. Stroke 2005, 36:715-719.
33. Grundy S.M., Pasternak R., Greenland P., Smith S., Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999, 100:1481-1492.
34. Van der Meer I., Iglesias D.S., Hak A.E., Bots M.L., Hofman A., Witteman J.C. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke 2003, 34:2374-2379.
35. Torzewski J., Torzewski M., Bowyer D.E., Frohlich M., Koenig W., Waltenberger J., et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998, 18:1386-1392.
36. Yasojima K., Schwab C., McGeer E.G., McGeer P.l. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001, 158:1039-1051.
37. Moshage H.J., Roelofs H.M., van Pelt J.F., Hazenberg B.P., van Leeuwen M.A., Limburg P.C., et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988, 155:112-117.
38. Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930-1932.
39. Jabs W.J., Theissing E., Nitschke M., Bechtel J.F., Duchrow M., Mohamed S., et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003, 108:1428-1431.